Additionally, the anti‐tumourigenic effect of ERβ in cancer cells could be a combination of downregulation of oncogenes such as PROX1, Myc, and MYB along with increased DNA repair capacity and induction of apoptosis (Figure 2). The gene discussed is PROX1; the disease is cancer.